The ACHIEVE Study and Beyond: Can Hearing Aids Slow Cognitive Decline?

One of the most active areas of hearing health research examines the relationship between hearing loss and cognitive function. Several landmark studies have shaped the current understanding.

The Foundational Research

In 2013, researchers led by Frank Lin at Johns Hopkins published a study in JAMA Internal Medicine that followed 1,984 older adults over six years. They found that participants with hearing loss experienced cognitive decline at a 30–40% faster rate than those with normal hearing.

Critically, the authors emphasized that this was an observational association, not evidence of direct causation. The study could not determine whether hearing loss causes cognitive decline or whether both conditions share common underlying factors.

Proposed Mechanisms

Researchers have proposed several theories for how hearing loss might contribute to cognitive changes:

• Cognitive load: When the brain must work harder to process degraded auditory signals, fewer resources are available for other cognitive tasks like memory and comprehension
• Brain atrophy: Some imaging studies have observed accelerated volume loss in auditory processing regions of the brain among adults with hearing loss
• Social isolation: Difficulty communicating leads to reduced social engagement, which is independently associated with cognitive decline

The ACHIEVE Trial

The Aging and Cognitive Health Evaluation in Elders (ACHIEVE) study is a landmark randomized controlled trial led by Johns Hopkins researchers. Published in The Lancet in 2023, it examined whether hearing intervention could slow cognitive decline in older adults.

Key findings:

• In the overall study population, the difference in cognitive decline between the hearing intervention group and the control group was not statistically significant
• However, in a pre-specified subgroup of participants at elevated risk for cognitive decline (from the ARIC study cohort), hearing intervention was associated with a 48% reduction in the rate of cognitive decline over three years
• Researchers have emphasized the need for longer follow-up to draw definitive conclusions

The Lancet Commission

In its 2020 report on dementia prevention, the Lancet Commission on Dementia identified hearing loss as the single largest modifiable risk factor for dementia, accounting for an estimated 8% of dementia cases globally. The commission recommended addressing hearing loss as part of a comprehensive approach to reducing dementia risk.

What This Means for Individuals

While the research is promising, it is important to note that no study has definitively proven that treating hearing loss prevents dementia or cognitive decline. The evidence suggests an association and a plausible biological basis, but individual outcomes vary.

What experts generally agree on: addressing hearing loss improves communication, social engagement, and quality of life — outcomes that are valuable regardless of any potential cognitive benefits.

This article is for informational purposes only. For concerns about hearing loss or cognitive health, consult a licensed healthcare provider.